Mercy Places First Commercial Eversense 365: The World’s First and Only 365-Day Continuous Glucose Monitor
Senseonics’ Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type…
Pharmaceuticals, Biotechnology and Life Sciences
Senseonics’ Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type…
High DAR Dual-Payload ADC Sutro unveils unique cell-free capabilities Proprietary cell-free platform enables the design of next-generation ADCs intended to…
Press Release €451M Revolving Credit Facility refinanced with a maturity extended to February 2029Issuance of a €200M Perpetual Deeply Subordinated…
Listing market: Euronext Paris (Market segment C – ISIN Code: FR001400K4B1- Symbol: PHXM) Website : www.phaxiam.com DateTotal of shares composing the…
NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) — Guggenheim Securities, LLC is issuing a statement on behalf of former Pfizer…
Strategic Agreements Unite Companies to Enhance Operational Synergies in the California Cannabis MarketSALINAS, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) —…
LOS ANGELES, Oct. 09, 2024 (GLOBE NEWSWIRE) — Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announced today…
RADNOR, Pa., Oct. 09, 2024 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today…
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 09, 2024 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical…
WESTLAKE VILLAGE, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced…